Evofem Biosciences, Inc. (EVFMD)

Last Closing Price: --

Free Cash Flow (Quarterly)

Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)

Evofem Biosciences, Inc. (EVFMD) had Free Cash Flow of $-0.63M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$4.63M
$0.86M
$0.75M
$3.88M
$3.89M
$0.74M
$0.26M
$1.00M
$1.00M
$1.00M
$1.00M
$1.00M
$1.00M
$0.74M
$0.79M
137.34M
6.81B
$0.01
$0.00
Balance Sheet Financials
$5.96M
$0.41M
$1.30M
$7.26M
$84.78M
--
$1.25M
$86.02M
$-83.93M
$-79.52M
$-78.76M
132.53M
Cash Flow Statement Financials
$-0.62M
$-0.00M
$0.37M
$0.58M
$0.32M
$-0.26M
$0.01M
--
--
Fundamental Metrics & Ratios
0.07
--
--
--
-0.67
83.79%
15.99%
15.99%
--
21.69%
18.69%
Free Cash Flow
$-0.63M
--
--
--
0.64
0.61
1.26
71.23
-1.20%
-1.26%
13.83%
-1.27%
$-0.59
$-0.00
$-0.00